Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Secondary Cytogenetic and Molecular Genetic Abnormalities in Newly Diagnosed Multiple Myeloma Patients

Jana Wobst, Marietta Truger, Natalie Wossidlo, Constance Regina Baer, Stephan Hutter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2024) 144 (Supplement 1): 899.

https://doi.org/10.1182/blood-2024-204832

Published: 2024

Journal Articles

Two Ways to Complex Karyotype in MDS - the Role of Del(5q) and TP53

Claudia Haferlach, Sandra Huber, Stephan Hutter, Constance Regina Baer, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, Torsten Haferlach

Blood (2024) 144 (Supplement 1): 1836.

https://doi.org/10.1182/blood-2024-201270

Published: 2024

Journal Articles

Similarities and Differences of DNMT3A , TET2 and ASXL1 Mutations across Ccus, MDS and AML

Sandra Huber, Stephan Hutter, Constance Regina Baer, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2024) 144 (Supplement 1): 1819.

https://doi.org/10.1182/blood-2024-200561

Published: 2024

Journal Articles

Mutational Landscape of SH2B3 -Mutated Hematologic Malignancies

Natalie Wossidlo, Khalid Shoumariyeh, Constance Regina Baer, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Manja Meggendorfer

Blood (2024) 144 (Supplement 1): 6689.

https://doi.org/10.1182/blood-2024-205394

Published: 2024

Journal Articles

Phenotypic and Genetic Heterogeneity of NPM1 Mutated AML at Diagnosis and during Course of Disease

Veronika Ecker, Sandra Huber, Wencke Walter, Stephan Hutter, Martha-Lena Mueller, Manja Meggendorfer, Constance Regina Baer, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern

Blood (2024) 144 (Supplement 1): 6118.

https://doi.org/10.1182/blood-2024-209675

Published: 2024

Journal Articles

Clonal Hematopoiesis Can Precede AML with Defining Cytogenetic Abnormalities - the Frequencies Vary Considerably

Anetta Marcinek, Constance Regina Baer, Stephan Hutter, Manja Meggendorfer, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach

Blood (2024) 144 (Supplement 1): 4318.

https://doi.org/10.1182/blood-2024-204966

Published: 2024

Journal Articles

Modification of the ELN Classification 2022 Refines Risk Assessment in MDS/AML Patients

Sandra Huber, Constance Regina Baer, Stephan Hutter, Frank Dicker, Irene Fuhrmann, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann

Blood (2023) 142 (Supplement 1): 61.

https://doi.org/10.1182/blood-2023-179822

Published: 2023

Journal Articles

M41 and Non-M41 UBA1 Variants Differ in Their Alteration of Hematopoiesis

Maki Sakuma, Constance Regina Baer, Manja Meggendorfer, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach, Wencke Walter

Blood (2023) 142 (Supplement 1): 1851.

https://doi.org/10.1182/blood-2023-188640

Published: 2023

Journal Articles

Classification of Philadelphia-Negative MPN As Low Risk and High Risk MPN Based on Peripheral Blood Values and Molecular Genetics Only

Sandra Huber, Gregor Hoermann, Manja Meggendorfer, Stephan Hutter, Constance Regina Baer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2023) 142 (Supplement 1): 3184.

https://doi.org/10.1182/blood-2023-174872

Published: 2023

Journal Articles

Lymphoma Cell Sorting to Enrich Low Degree Infiltration Clonal B-Cells for Diagnostic Delineation of Molecular Genetic Background By NGS

Veronika Ecker, Martha-Lena Mueller, Manja Meggendorfer, Christiane Eder, Constance Regina Baer, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern

Blood (2023) 142 (Supplement 1): 6101.

https://doi.org/10.1182/blood-2023-188953

Published: 2023

Journal Articles

DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma

Blood (2023) 142 (Supplement 1): 174.

https://doi.org/10.1182/blood-2023-189835

Published: 2023

Journal Articles

Parallel Genomic Analysis from Paired Bone Marrow and Peripheral Blood Samples of 200 Cytopenic Patients

Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Isolde Summerer, Henning Ruge, Constance Regina Baer, Wolfgang Kern, Claudia Haferlach

Blood (2023) 142 (Supplement 1): 198.

https://doi.org/10.1182/blood-2023-174843

Published: 2023

Journal Articles

Genomic Landscape of Ccus Compared to MDS Indicates a Potential Applicability of the IPSS-M

Sandra Huber, Constance Regina Baer, Stephan Hutter, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2023) 142 (Supplement 1): 4609.

https://doi.org/10.1182/blood-2023-177582

Published: 2023

Journal Articles

Characterization of Cases with the Rare Cytogenetic Abnormality I(7)(p10) Reveals an Association with IDH2 Mutated Acute Myeloid Leukemia

Anna Stengel, Manja Meggendorfer, Constance Regina Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2023) 142 (Supplement 1): 5987.

https://doi.org/10.1182/blood-2023-179844

Published: 2023

Journal Articles

Whole Genome and Transcriptome Sequencing of 21 Paired Chronic and Blast Phase CML Cases: Acquisition of Genomic Alterations, Changes in the Transcriptomic Profiles and Occurrence of B-Cell Receptor Rearrangements

Claudia Haferlach, Wencke Walter, Heiko Mueller, Sandra Huber, Constance Regina Baer, Stephan Hutter, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, Torsten Haferlach

Blood (2023) 142 (Supplement 1): 3170.

https://doi.org/10.1182/blood-2023-185867

Published: 2023

Journal Articles

Proposal ofmyeloid Neoplasms with MYC -Positive Double Minutes As a Distinct Entity

Isolde Summerer, Wencke Walter, Manja Meggendorfer, Torsten Haferlach, Frank Dicker, Stephan Hutter, Niroshan Nadarajah, Constance Regina Baer, Anna Stengel, Wolfgang Kern, John M. Bennett, Claudia Haferlach, Christian Pohlkamp

Blood (2023) 142 (Supplement 1): 2930.

https://doi.org/10.1182/blood-2023-189902

Published: 2023

Journal Articles

The Frequency of Clonal Hematopoiesis Prior to AML and MDS Varies Among the Different Molecularly Defined Who Subtypes

Constance Regina Baer, Sandra Huber, Gregor Hoermann, Manja Meggendorfer, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2023) 142 (Supplement 1): 725.

https://doi.org/10.1182/blood-2023-179737

Published: 2023

Journal Articles

A Proposal for a Classification of Ccus, MDS and AML Primarily Based on Genetic Abnormalities Considering the Biological Continuum of These Entities

Claudia Haferlach, Sandra Huber, Constance Regina Baer, Stephan Hutter, Manja Meggendorfer, Wolfgang Kern, Gregor Hoermann, Torsten Haferlach

Blood (2023) 142 (Supplement 1): 6492.

https://doi.org/10.1182/blood-2023-179188

Published: 2023

Journal Articles

Detection of ABL1 kinase Domain Mutations in Therapy Naive BCR-ABL1 Positive ALL

Constance Regina Baer, PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 3972.

https://doi.org/10.1182/blood.V130.Suppl_1.3972.3972

Published: 2017

Journal Articles

Mutation Screening at Diagnosis Reveals a High Frequency of ASXL1 Mutations in CML Patients Who Fail to Achieve Molecular Remission Criteria after One Year of TKI Treatment

Constance Regina Baer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 1585.

https://doi.org/10.1182/blood.V130.Suppl_1.1585.1585

Published: 2017

NARROW

Secondary Cytogenetic and Molecular Genetic Abnormalities in Newly Diagnosed Multiple Myeloma Patients

Two Ways to Complex Karyotype in MDS - the Role of Del(5q) and TP53

Similarities and Differences of DNMT3A , TET2 and ASXL1 Mutations across Ccus, MDS and AML

Mutational Landscape of SH2B3 -Mutated Hematologic Malignancies

Phenotypic and Genetic Heterogeneity of NPM1 Mutated AML at Diagnosis and during Course of Disease

Clonal Hematopoiesis Can Precede AML with Defining Cytogenetic Abnormalities - the Frequencies Vary Considerably

Modification of the ELN Classification 2022 Refines Risk Assessment in MDS/AML Patients

M41 and Non-M41 UBA1 Variants Differ in Their Alteration of Hematopoiesis

Classification of Philadelphia-Negative MPN As Low Risk and High Risk MPN Based on Peripheral Blood Values and Molecular Genetics Only

Lymphoma Cell Sorting to Enrich Low Degree Infiltration Clonal B-Cells for Diagnostic Delineation of Molecular Genetic Background By NGS

DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma

Parallel Genomic Analysis from Paired Bone Marrow and Peripheral Blood Samples of 200 Cytopenic Patients

Genomic Landscape of Ccus Compared to MDS Indicates a Potential Applicability of the IPSS-M

Characterization of Cases with the Rare Cytogenetic Abnormality I(7)(p10) Reveals an Association with IDH2 Mutated Acute Myeloid Leukemia

Whole Genome and Transcriptome Sequencing of 21 Paired Chronic and Blast Phase CML Cases: Acquisition of Genomic Alterations, Changes in the Transcriptomic Profiles and Occurrence of B-Cell Receptor Rearrangements

Proposal ofmyeloid Neoplasms with MYC -Positive Double Minutes As a Distinct Entity

The Frequency of Clonal Hematopoiesis Prior to AML and MDS Varies Among the Different Molecularly Defined Who Subtypes

A Proposal for a Classification of Ccus, MDS and AML Primarily Based on Genetic Abnormalities Considering the Biological Continuum of These Entities

Detection of ABL1 kinase Domain Mutations in Therapy Naive BCR-ABL1 Positive ALL

Mutation Screening at Diagnosis Reveals a High Frequency of ASXL1 Mutations in CML Patients Who Fail to Achieve Molecular Remission Criteria after One Year of TKI Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only